WorldPing ← All news

STAT8/10/2026, 11:31:00 AM

STAT+: Silence Therapeutics aims at Takeda with new data in rare blood cancer

STAT+: Silence Therapeutics aims at Takeda with new data in rare blood cancer

WorldPing

A rare blood cancer drug from Silence Therapeutics showed strong results in a trial, potentially setting it up to compete with a Takeda medicine.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

Related news

STAT+: Heart failure drug from Tenax Therapeutics fails in pivotal study

WorldPing

STAT

STAT+: Heart failure drug from Tenax Therapeutics fails in pivotal study

A Tenax Therapeutics drug designed to treat a type of heart failure associated with high blood pressure in the lungs failed in a closely watched study.

Brief by WorldPing · Original reporting by STAT